Used 3 methods of assessing behavioral disturbance in 79 children presenting with poor school performance to an interdisciplinary evaluation center. Findings revealed a very high frequency of behavior problems, particularly of the internalizing type, but few differences in frequency or type of behavior problems among 4 subgroups: children with learning disabilities, mental retardation, borderline intellectual functioning, and without learning disabilities or cognitive impairment. Behavioral problems were associated with lower perceptions of self-worth and family functioning characterized as more controlling, and less supportive. Findings are discussed in terms of the need for interactional models of learning and behavior problems.
BRITISH 431 478) gives the impression that both populations were known to be drawn from the same area. The selection of the mining population by panel attendance and death imposes an inevitable and strong bias and leaves unknown the population of living miners and ex-miners (with or without pneumoconiosis) from the same decades and areas of the deceased miners and ex-miners. The absence of an age gradient of emphysema in the mining group compared with the contrast group would seem to confirm this bias. The explanation given that confluent fibrotic lesions may have obscured emphysema is improbable as no gradient in men with category "O" to "A" was demonstrated. This point has alco been commented on by Dr. C. M. Fletcher (17 October, p. 176). We cannot accept that the difference in the prevalence of emphysema found to exist between the miners and the contrast population is representative of the real difference between miners as a whole and the general population. Nor do we think the authors have demonstrated an excess of any particular type of emphysema among the miners with pneumoconiosis.-We are, etc.,
Purpose: To assess the safety and efficacy of percutaneous sclerotherapy of slow-flow vulvar vascular malformations. Materials: An IRB-approved retrospective review was undertaken of all patients who underwent percutaneous sclerotherapy of slow-flow vulvar vascular malformations between January 2008 and August 2017. Patient demographics, lesion characteristics, procedural factors, and clinical outcomes were identified through a review of the electronic medical record and relevant imaging. Results: Seven female patients (ages 7-32 years) with slow-flow vulvar vascular malformations underwent a total of 14 percutaneous sclerotherapy treatments using the 3% sodium tetradecyl sulfate foam technique. Two cases were associated with Klippel-Tr enaunay syndrome and one with Servelle-Martorell syndrome. Presenting symptoms included generalized pain or discomfort (n ¼ 6), dyspareunia (n ¼ 1), voiding difficulties (n ¼ 1), and cosmetic concerns (n ¼ 1). All sclerotherapy procedures were technically successful. Clinical follow-up was available in six patients. Two patients reported near-complete resolution of symptoms after a single treatment. Three patients experienced initial relief but developed symptomatic recurrence after one year and required repeat treatment with subsequent resolution of symptoms. One patient experienced a gradual improvement in symptoms requiring a total of five treatments. One procedure (7.1%) resulted in minor labial cutaneous ulceration which resolved with conservative management. There were no major complications. Conclusions: Percutaneous sclerotherapy of slow-flow vulvar vascular malformations proved safe and effective in this limited cohort. While repeat therapy was necessary in the majority of cases, nearly all patients experienced durable symptomatic relief.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.